Table 3 FUT2 (rs601338) and ABO (rs505922) main and stratified effects in the COPSACsevere study (discovery), and the COPSAC birth cohorts (replication).

From: FUT2ABO epistasis increases the risk of early childhood asthma and Streptococcus pneumoniae respiratory illnesses

Discovery (COPSACsevere)

Gene

Analysis

OR [95% CI]

P value

Cases/controls

FUT2

Main effect

1.17 [1.07–1.29]

0.001

1204/5328

ABO = TT

0.94 [0.81–0.10]

0.45

410/2199

ABO = TC

1.29 [1.13–1.48]

2.0×10−4

623/2435

ABO = CC

1.54 [1.18–2.02]

0.001

171/694

ABO

Main effect

1.16 [1.05–1.27]

0.002

1204/5328

FUT2 = AA

0.83 [0.65–1.05]

0.12

194/1095

FUT2 = AG

1.12 [0.98–1.28]

0.10

612/2624

FUT2 = GG

1.43 [1.21–1.69]

2.2×10−5

398/1609

FUT2 × ABO

Interaction

1.29 [1.12–1.48]

3.2×10−4

1204/5328

Replication (COPSAC birth cohorts)

FUT2

Main effect

1.31 [1.04; 1.67]

0.02

191/727

ABO = TT

0.99 [0.67; 1.47]

0.96

64/317

ABO = TC

1.38 [0.99; 1.94]

0.06

103/327

ABO = CC

2.44 [1.20; 5.30]

0.02

24/83

ABO

Main effect

1.27 [1.00; 1.62]

0.05

191/727

FUT2 = AA

0.94 [0.49; 1.73]

0.84

27/142

FUT2 = AG

1.10 [0.78; 1.55]

0.57

93/367

FUT2 = GG

1.93 [1.26; 3.00]

0.003

71/218

FUT2 × ABO

Interaction

1.50 [1.05; 2.17]

0.03

191/727

Risk score

2.82 [1.56; 5.10]

5.7×10−4

191/727

  1. The logistic regression models were adjusted for ten principal components and sex for the discovery and for cohort status and sex for the replication. The reported P values are not corrected for multiple comparisons.
  2. P < 0.05 is in bold.